22^nd International Conference on Cancer Biology and Cell Science September 19-20, 2024 Paris, France

Triple-negative breast cancer (TNBC) represents a unique subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. This track will delve into the intricate pathology of TNBC, exploring its clinical implications and therapeutic strategies. Attendees will gain insights into the aggressive nature of TNBC, its distinct molecular features, and the challenges associated with diagnosis and treatment. Discussion will focus on emerging biomarkers, novel targeted therapies, and immunotherapy approaches. By understanding the underlying pathology of TNBC, participants will be equipped to optimize patient management, improve prognostic evaluation, and contribute to the development of personalized therapeutic interventions.

Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists" emphasizes the significance of teamwork and cooperation among healthcare professionals involved in the diagnosis, treatment, and management of breast pathology. This track highlights the importance of integrating the expertise of pathologists, radiologists, surgeons, and oncologists to ensure comprehensive patient care. Discussions within this track will focus on effective communication, interdisciplinary tumor board meetings, shared decision-making, and the latest advancements in collaborative practices. By fostering a multidisciplinary approach, this track aims to enhance diagnostic accuracy, optimize treatment planning, and improve patient outcomes in the field of breast pathology

The track on "Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations" focuses on the complexities and unique aspects of assessing breast tissue following reconstructive procedures. This track explores the challenges faced by pathologists when evaluating post-reconstruction specimens, including distinguishing normal tissue from residual or recurrent cancer, identifying implant-associated changes, and interpreting the effects of radiation therapy. Additionally, it delves into the histopathological evaluation of various types of breast reconstructions, such as autologous flaps and implant-based reconstructions, addressing the impact of surgical techniques on pathological assessment. This track aims to enhance understanding, promote best practices, and foster collaboration between pathologists and reconstructive surgeons in optimizing the assessment of reconstructed breast tissue.

The track "Breast Imaging: Innovations in Radiology and Pathology Correlation" focuses on the latest advancements in imaging techniques for breast pathology and the correlation between radiological findings and pathological assessment. This track will delve into cutting-edge innovations in breast imaging, such as digital mammography, tomosynthesis, magnetic resonance imaging (MRI), and molecular imaging modalities. Discussions will revolve around the integration of imaging findings with pathological analysis to enhance diagnostic accuracy, improve treatment planning, and optimize patient outcomes. Attendees will gain insights into the evolving field of breast imaging, explore the challenges and opportunities in radiology-pathology correlation, and understand the implications for clinical decision-making in breast pathology

This track focuses on the diagnostic challenges encountered in the spectrum of breast lesions, specifically from atypical ductal hyperplasia (ADH) to ductal carcinoma in situ (DCIS). With the increasing use of and detection techniques, the identification and accurate diagnosis of these lesions have become crucial for appropriate patient management. This track explores the complexities involved in distinguishing between ADH and DCIS, discussing the overlapping morphological features, immunohistochemical markers, and molecular characteristics that aid in differential diagnosis. The track also highlights the latest advancements in diagnostic tools, including genomic profiling and molecular testing, aiming to enhance diagnostic accuracy and guide optimal treatment strategies for patients with ADH and DCIS.

This track focuses on the latest advancements in molecular pathology techniques and their application in unraveling the intricate subtypes of breast cancer. With the advent of genomic profiling and molecular markers, this session aims to explore the diverse molecular landscapes that underlie breast cancer, including hormone receptor-positive, HER2-positive, and triple-negative subtypes. Experts will discuss the molecular signatures, genomic alterations, and gene expression profiles associated with these subtypes, enabling a deeper understanding of their unique characteristics and implications for prognosis and treatment. Attendees will gain insights into the evolving field of molecular pathology, its impact on breast cancer classification, and the potential for personalized therapeutic interventions.

Vaccines are pills that provide the body's protection against disorders. Vaccines can educate our immune systems to look for and eliminate risky cells, microorganisms, and pathogens. We get hold of a ramification of vaccines at some point in our lives to defend against commonplace sicknesses or illnesses. Additionally, vaccinations for cancer or tumors are without trouble. Some vaccines can be used to cure and prevent cancer. A few vaccines protect against developing some malignancies added on via viruses. Most effectively, those who receive this form of immunization prior to contracting the virus will gain from it. With a view to better recognizing the biology of HCC, research into the molecular biology of hepatocarcinogenesis has diagnosed numerous biomarkers that could offer additional evidence.

Cancer Societies: Children's Cancer Association | French Society of Oncology Pharmacy | Belgian Association of Oncological Radiotherapy | Cancer Registry Bavaria | European Cancer Organization |

The Clinical session on the finer points of existence and supportive care makes a specialty of addressing the multidimensional factors of sufferers' well-being and imparting comprehensive support at some point of their most cancerous adventure. The consultation ambitions to discover numerous strategies, interventions, and research associated with enhancing the satisfactory of lifestyles and presenting supportive care offerings to individuals tormented by cancer. This medical session delves into multidimensional factors of cancer sufferers' well-being, exploring techniques and interventions to beautify their satisfactory of life. The point of interest is on comprehensive supportive care in the course of the cancer journey.

Cancer Societies: Children's Cancer Association | French Society of Oncology Pharmacy | Belgian Association of Oncological Radiotherapy | Cancer Registry Bavaria | European Cancer Organization |

Cancers is a disease, which entails the odd growth of cells that bring about the formation of a tumor. But benign tumors aren't cancers. The perticular tumor cells have the tendency to spread to different local tissues and  also unfold to specific components of body through blood and lymphatic gadget.The  Special form of cancers including lung cancer, colorectal, breast cancers and others are main a few of the popular. Remedy of most cancers depends  upon  the tiers of the ailment development. Chemotherapy is mostly used in the sooner degrees while other therapy options inclusive of targeted therapy pills, immunological remedy tablets are used in past due stage.

• Metastatic symptoms
• Clinical Research
• Drug Discovery and Delivery
• Genetics, Genomics, and Proteomics
• Cell, Molecular, and Stem Cell Biology
• Chemotherapy
• Bone Marrow Transplantation
• Hormone Replacement Therapy
• Surgery and Laparoscopy
• Molecular Targeted Therapies
• Natural Therapy and Acupuncture
• Carcinogenesis

In most cases, Innovation may be described simply as "new ideas, devices, or methods.". But the  innovation is often, moreover, regarded as the utility for better solutions that meet a new requirements, unarticulated goals, or modern-day marketplace wishes. This is executed through more powerful products, strategies, services, technology, or business models that are without trouble available to markets, governments and society. The term of "innovation" can be defined something as precise and more powerful and, as a result, new, that "breaks into" the market or society. Most cancer innovation involves novel ideas and answers, addressing unmet needs in healthcare. It manifests through advanced merchandise, technologies, and offerings, contributions to improved patient outcomes and societal well-being.

Cancer Societies: Children's Cancer Association | French Society of Oncology Pharmacy | Belgian Association of Oncological Radiotherapy | Cancer Registry Bavaria | European Cancer Organization |

Mobile signaling (cellular signaling in British English) is a part of any communication method that governs the primary sports activities of cells and coordinates all cellular actions. The functionality of cells to understand and successfully reply to their microenvironment  the idea of improvement, tissue repair, and immunity, as well as a regular tissue homeostasis. Mistakes in signalling a interactions and cell information is  processing are responsible for illnesses such as a  most cancers, are  autoimmunity, and diabetes. By way of the usage of know-how in mobile signaling, sicknesses can be dealt with extra efficiently, and, theoretically, artificial tissues may be created. Cell demise is the occasion of an organic cellular ceasing to carry out its capabilities. This will be the cease end result of the natural procedure of vintage cells losing their lifestyles and being replaced by the latest ones, or it may be also result from such elements as sickness, localized harm, or the demise of the organism of which the cells are detail.

Advances in radiation therapy are revolutionizing breast cancer treatment, offering precise and targeted approaches to destroy cancer cells while minimizing damage to healthy tissue. Techniques likes a intensity-modulated radiation therapy (IMRT) and proton therapy deliver radiation with pinpoint accuracy, reducing side effects and improving outcomes.

Hypofractionated radiation schedules shorten treatment durations, making it more convenient for patients. Image-guided radiation therapy (IGRT) uses real-time imaging to adjust treatment, ensuring accuracy.

Intraoperative radiation therapy (IORT) delivers a single dose of radiation during surgery, sparing healthy tissue. These advancements in the radiation therapy enhance effectiveness, and  reduce treatment times, and improve the quality of life for a  breast cancer patients, marking a significant stride in the fight against the disease.

Chemotherapy is a systemic treatment that uses a drugs to target and destroy rapidly dividing cancer cells throughout the body. It is commonly used in the treatment of breast cancer to shrink tumors, prevent cancer from spreading, and destroy any cancer cells that may remain after surgery. Chemotherapy might also  used in combination with other treatments, such as surgery, radiation therapy, hormone therapy, and targeted therapy.

• Effectiveness and Monitoring
• Management of Side Effects
• Psychological Support

In breast cancer care, lifestyle choices play a vital role in prevention and survivorship. Healthy habits like regular exercise, a balanced diet, and avoiding smoking can lower the risk of developing breast cancer and improve outcomes for survivors.

Preventive measures also include a regular screenings, such as mammograms, to detect cancer early when treatment is most effective. For survivors, survivorship care plans focus on monitoring for recurrence, managing side effects, and promoting overall well-being.

Support of  groups, counseling, and survivorship programs offer emotional and mental support. By adopting a healthy lifestyle, staying vigilant with screenings, and accessing survivorship resources, individuals can enhance their journey through breast cancer and beyond.

Breast cancer is a complex and prevalent disease characterized by the uncontrolled growth of cells in  the breast tissue. It effects the both men and women, with women being more commonly diagnosed.The  Early detections play  a crucial role in improving outcomes. Regular self-examinations, clinical screenings, and mammograms aid in identifying potential abnormalities at an early, more treatable stage.

Breast cancer can be categorized based on its receptors—hormone receptor-positive (HR+), HER2-positive, and triple-negative. Each type of demands tailored treatment approaches, including surgery, chemotherapy, radiation, targeted therapy, and hormonal therapy. Researchers and medical professionals continue to make strides in understanding about the disease, comprehensively care, early intervention, and collaborative efforts remain vital in the fight against the breast cancer.

• Chemotherapy
• Malignancy
• Radiation Therapy

Pores and skin most cancers is malignant growths that create from the skin. This  may be because of  movement of anomalous cells that may attack or unfold to distinct portions of  Body. There are three numbers one kinds of skin malignant growths: basal-cellular skin ailment (BCC), squamous-cellular pores and skin sickness (SCC) and melanoma. The lymphomas start inside the skin are called skin lymphoma. Careful extraction is the maximum well-known form of therapy for pores and skin tumors. Around 90% of non-cancer pores and skin malignant growths are helped with presentation to vivid (UV) radiation from the sun. Sunscreen is strong on  this way prescribed to deflect cancer and squamous-cell carcinoma.

• Basal cell skin cancer
• Squamous cell skin cancer
• Skin lymphoma
• Melanoma
• Signs and Symptoms

Oncogenomicsid is a part of genomics that portrays malignancy associated features. It centers round genomic, non inherted  and report changes in cruelty. The development from usual tissue to cause forceful malignant growth is idea to occur over a timescale of 5–20 years. This change is detect  by a  means of booth obtained genetically

 components and vast hereditary changes and ameliorations, and it brings approximately out of control cell development and activates death. The heredity changes that lead to malignant increase happen just in specific characters. Disease inflicting qualities were named proto-oncogenes (e.g., the traits for MYC, ERBB2 and EGFR) and tumor silencer traits, for example, the features that encode TP53, CDKN2A, and RB. The end of the Human Genome project rearranged the sector of oncogenomic and progressed the capacities of specialists to discover oncogenes. Sequencing improvements and worldwide methylation profile strategies have been drilled for  the research of oncogenomics.

• Tumor suppressor genes
• Functional analysis of oncogene
• Heredity cancer syndrome
• Carcinogenic driver mutation
• Databases for cancer research